There is a way to get immune cells to fight cancer. Chimeric antigen receptor (CAR) T-cell therapy collects the T cells from the patient and makes a small change to the cells. These specially altered T cells fight cancer. In this context, the Marie Skłodowska-Curie Actions project InnoCAR-T will provide training and carry out breakthrough research to develop next-generation CAR-T therapy. Specifically, the project will develop innovative manufacturing solutions for CAR-T production. It will also develop the next generation of more effective CAR-Ts. The project is designed to assist young scientists in generating breakthrough ideas in immunology, CAR engineering and gene editing.